Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-20

Clinical Trial Update: Efficacy Study of Mirtazapine to Treat Interferon-related Depression During Antiviral Therapy for Hepatitis C [Phase 4]

View source ↗

Summary

Phase 4 trial updating efficacy of mirtazapine for interferon-related depression during antiviral therapy for hepatitis C; the study is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • mirtazapine (mirtazapine)

Snippet

Sponsor: Seoul National University Boramae Hospital | Conditions: Depression | Phase 4 | Status: TERMINATED